High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone.
第一作者:
Andreas,Pfützner
第一单位:
IKFE, Institute for Clinical Research and Development, Mainz, Germany. AndreasP@ikfe.de
作者:
医学主题词
动脉粥样硬化(Atherosclerosis);C反应蛋白质(C-Reactive Protein);心血管疾病(Cardiovascular Diseases);糖尿病(Diabetes Mellitus);人类(Humans);降血糖药(Hypoglycemic Agents);炎症(Inflammation);危险因素(Risk Factors);敏感性与特异性(Sensitivity and Specificity);噻唑烷二酮类(Thiazolidinediones)
DOI
10.1177/193229681000400326
PMID
20513338
发布时间
2022-03-10
- 浏览17
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



